Hormonoprophylaxis and hormonotherapy in the treatment of endometrial adenocarcinoma by means of medroxyprogesterone acetate
- 1 February 1978
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 6 (1), 60-75
- https://doi.org/10.1016/0090-8258(78)90006-9
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Hormones and gynecologic cancerCancer, 1976
- Progesterone binding in human endometrial carcinomasAmerican Journal of Obstetrics and Gynecology, 1976
- Progesterone Binding by Normal and Abnormal Human EndometriumJournal of Clinical Endocrinology & Metabolism, 1976
- Oestradiolund Progesteron-bindende Receptoren sowie 17?-Hydroxysteroiddehydrogenase in Endometriumcarcinomen der Frau vor und nach Gestagen-BehandlungZeitschrift für Krebsforschung und Klinische Onkologie, 1976
- EFFECT OF GESTAGEN THERAPY UPON 17β-HYDROXYSTEROID DEHYDROGENASE IN HUMAN ENDOMETRIAL ADENOCARCINOMAJournal of Endocrinology, 1975
- EFFECTS OF PROGESTINS ON ESTRADIOL RECEPTOR LEVELS IN HUMAN ENDOMETRIUMJournal of Clinical Endocrinology & Metabolism, 1975
- Progesterone “Receptor” in Human EndometriumEndocrinology, 1974
- Estradiol and 20α-Dihydroprogesterone Dehydrogenase Activities in Human Endometrium During the Menstrual CycleEndocrinology, 1974
- In vitro binding of progesterone by the human endometrium during the menstrual cycle and by hyperplastic, atrophic and carcinomatous endometriumJournal of Steroid Biochemistry, 1972
- Histological effects of progestins on hyperplasia and carcinoma in situ of the endometrium—Further observationsMetabolism, 1965